A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: r. peter Dale who wrote (43)	8/28/1997 6:26:00 PM
From: shero	of 171

They took Techniclone (TCLN) out and shot the horse over the last two days. I'm a long term shareholder and a frequent poster on that thread. They have enough money for about 1 year, one drug in Phase 3 clinicals (its taking forever) and another blockbuster (if it works) drug going into clinicals in the US in 4th quarter 97 and in Europe in 98. Their European partner is Cambridge, the leader in human monoclonals. I think the next 12 months will be very interesting for the company, and hopefully the shareholders. There is other technology I haven't talked about. Also, and a big plus is the company is searching for a new CEO. Its a gamble--what bio-tech isn't--but worth a look. Shero

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next